๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Alcohol Related Liver Disease

Acquisition of Cardiac Function Parameters in MRI and Echocardiography in Patients With Ethyltoxic Liver Cirrhosis and Transjugular Intrahepatic Portosystemic Shunt (TIPSS) Placement NCT06814990NA1 site๐Ÿ“ Jena Stephanie Grรคger ยท Tests: Cardiac MRI, Blood samples, Echocardiography Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a1 site๐Ÿ“ Sioux Falls Sanford Health Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States NCT05832229Phase 213 sites๐Ÿ“ La Jolla๐Ÿ“ Los Angeles๐Ÿ“ Los Angeles National Institute of Diabetes and Digestive and Kidney Disโ€ฆ ยท Tests: Rosuvastatin Health Literacy and Self-efficacy Expectations in Patients With Alcohol-related Liver Cirrhosis NCT07169526n/a1 site๐Ÿ“ Hanover Hannover Medical School Hepatic Lipid Metabolism-Alcohol Use Disorder NCT07191561n/a1 site๐Ÿ“ Bethesda National Institute of Diabetes and Digestive and Kidney Disโ€ฆ ยท Tests: Liver biopsy Recompensation in Alcohol Related Hepatitis NCT06740318NA1 site๐Ÿ“ Hvidovre Nina Kimer ยท Tests: Motivational enhancement therapy Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH) NCT07428538Phase 392 sites๐Ÿ“ Birmingham๐Ÿ“ Mobile๐Ÿ“ Phoenix Bausch Health Americas, Inc. ยท Tests: Larsucosterol, Placebo Comparison of ALD, NASH, and Healthy Control Patients NCT03224949n/a1 site๐Ÿ“ Cleveland The Cleveland Clinic ยท Tests: Blood draw Peripheral Blood Mononuclear Cells Response In Healthy Controls, Heavy Drinkers, and Patients With Alcoholic Hepatitis NCT04088370n/a1 site๐Ÿ“ Cleveland The Cleveland Clinic ยท Tests: Blood Draw Efficacy of Simvastatin in Alcoholic Liver Fibrosis NCT04971577Phase 2, Phase 31 site๐Ÿ“ Barcelona Anna Cruceta ยท Tests: Simvastatin 40mg Clinical Trial to Evaluate the Efficacy and Safety of Cellgram-LC Administration in Patients With Alcoholic Cirrhosis NCT04689152Phase 315 sites๐Ÿ“ Ansan๐Ÿ“ Bucheon-si๐Ÿ“ Cheonan Pharmicell Co., Ltd. ยท Tests: Cellgram-LC, Best Supportive Care (BSC) Exercise Training Decreases Alcohol Consumption and Tissue Injury by an FGF21-dependent Mechanism NCT07824089NA1 site๐Ÿ“ Cleveland The Cleveland Clinic ยท Tests: Endurance Exercise A Large Language Model-based Chatbot for Alcohol Reduction in Patients With Metabolic Alcohol-Related Liver Disease NCT07450144NA1 site๐Ÿ“ Hong Kong The University of Hong Kong ยท Tests: LLM-based chatbot, Telephone counseling, Alcohol Brief Intervention Study of Genetic Determinants in Alcoholic Hepatitis and Establishment of a Multicenter Prospective Cohort of Patients With Alcoholic Liver Disease NCT04106518n/a9 sites๐Ÿ“ Angers๐Ÿ“ Besanรงon๐Ÿ“ Bondy University Hospital, Lille Investigating HepQuant DuO Test as a Biomarker in Alcohol-related Liver Disease NCT07060547n/a1 site๐Ÿ“ Redwood City HepQuant, LLC ยท Tests: HepQuant DuO Test Implementation Facilitation Pilot for Alcohol Use Disorder (AUD) in Alcohol-associated Liver Disease (ALD) NCT07525258NA1 site๐Ÿ“ New Haven Yale University ยท Tests: Implementation Intervention Enhancing Alcohol Treatment Engagement in Associated Liver Disease (ALD) Patients NCT06269510NA1 site๐Ÿ“ Detroit Henry Ford Health System ยท Tests: ENGAGE-ALD Application (APP), Treatment Facilitation bundle, Enhanced Usual Care Screening At-risk Populations for Hepatic Fibrosis With Non-invasive Markers NCT03308916NA1 site๐Ÿ“ Odense Maja Thiele ยท Tests: transient elastography, Enhanced liver fibrosis test, Indirect serum markers of liver fibrosis, Direct serum markers ofโ€ฆ Faecal Microbiota Transplantation for Liver Cirrhosis NCT04932577Phase 2, Phase 31 site๐Ÿ“ Aarhus University of Aarhus ยท Tests: Faecal microbiota transplantation, Placebo Peer Support for Liver Transplant Recipients With History of ALD NCT07397598NA1 site๐Ÿ“ Baltimore Johns Hopkins University ยท Tests: Peer Support Study of HMB-enriched Amino Acid Supplementation in Patients With Alcoholic Liver Disease and COVID-19 NCT04858412NA1 site๐Ÿ“ Cleveland The Cleveland Clinic ยท Tests: ฮฒ-hydroxy ฮฒ-methyl butyrate (HMB) enriched amino acid, Balanced amino acid HA35 Moderate Alcoholic Hepatitis (AH) Study NCT05018481EARLY Phase 11 site๐Ÿ“ Cleveland The Cleveland Clinic ยท Tests: Sodium Hyaluronate, Placebo Ethanol Induces Skeletal Muscle Autophagy NCT03209791n/a1 site๐Ÿ“ Cleveland The Cleveland Clinic ยท Tests: Biopsies Risk and Protective Factors for Relapse to Alcohol Use in Patients With Liver Disease Undergoing Liver Transplantation NCT06749990n/a1 site๐Ÿ“ Bologna IRCCS Azienda Ospedaliero-Universitaria di Bologna A Study to Investigate the Safety and Efficacy of Efimosfermin Alfa Compared With Placebo in Adult Participants With Alcohol-related Liver Disease (ALD) NCT07791043Phase 24 sites๐Ÿ“ Topeka๐Ÿ“ Fort Worth๐Ÿ“ San Antonio GlaxoSmithKline ยท Tests: Efimosfermin alfa, Placebo Implementation of Mobile-based Programs for Alcohol Cessation in Treatment of Alcohol-associated Liver Disease NCT06305624NA3 sites๐Ÿ“ Lansing๐Ÿ“ Madison๐Ÿ“ Madison University of Wisconsin, Madison ยท Tests: Connections App A PROspective Faecal MIcrobiota tranSplantation Trial to Improve outcomEs in Patients With Cirrhosis NCT06461208Phase 323 sites๐Ÿ“ Basildon๐Ÿ“ Bournemouth๐Ÿ“ Bristol King's College London ยท Tests: Encapsulated FMT, Placebo Optimized Remission in Alcohol-related Liver Cirrhosis NCT06866496NA1 site๐Ÿ“ Hvidovre Copenhagen University Hospital, Hvidovre ยท Tests: Motivational interviews, Standard of Care (SOC) Safety and Efficacy of Fecal Microbiota Transplantation NCT04014413NA1 site๐Ÿ“ Hong Kong Chinese University of Hong Kong ยท Tests: Fecal Microbiota Transplantation A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease NCT06613698Phase 2140 sites๐Ÿ“ Chandler๐Ÿ“ Phoenix๐Ÿ“ Tucson GlaxoSmithKline ยท Tests: GSK4532990, Placebo
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy